Signaling in the suprachiasmatic nucleus: selectively responsive and integrative

被引:150
作者
Gillette, MU
Mitchell, JW
机构
[1] Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA
[3] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA
关键词
PACAP; glutamate; cAMP; phase shift; melatonin; cGMP; acetylcholine; SCN;
D O I
10.1007/s00441-002-0576-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The suprachiasmatic nucleus (SCN) contains a biological clock that generates timing signals that drive daily rhythms in behaviors and homeostatic functions. In addition to this pacemaker function, the SCN gates its own sensitivity to incoming signals, which permits appropriate temporal adjustment to achieve synchrony with environmental and organismic states. A series of time-domains, in which the SCN restricts its own sensitivity to a limited set of stimuli that adjust clock phase, can be distinguished. Pituitary adenylyl cyclase-activating peptide (PACAP) and cAMP directly reset clock phase during the daytime domain, both cause phase advances only during the clock's day-time domain, but are without effect at night. In contrast, acetylcholine and cGMP analogs phase advance the clock only when applied during the night. Sensitivity to light and glutamate arises concomitant with sensitivity to acetylcholine and cGMP. Light and glutamate cause phase delays in the early night, by elevating intracellular Ca2+ via neuronal ryanodine receptors. In late night, light and glutamate utilize a cGMP-mediated mechanism to induce phase advances. Nocturnal responses of SCN primed by light or glutamate can be modulated by effectors of phase-resetting in daytime, namely, PACAP and cAMP. Finally, the dusk and dawn domains are characterized by sensitivity to the pineal hormone, melatonin, acting through protein kinase C. These changing patterns of sensitivities demonstrate that the circadian clock controls multiple intracellular gates, which ensures that they can be opened selectively only at specific points in the circadian cycle. Discerning the molecular bases of these changes is fundamental to understanding integrative and regulatory mechanisms in the circadian system.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 57 条
[31]   Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: Activation of protein kinase C at dusk and dawn [J].
McArthur, AJ ;
Hunt, AE ;
Gillette, MU .
ENDOCRINOLOGY, 1997, 138 (02) :627-634
[32]   SEROTONIN REGULATES THE PHASE OF THE RAT SUPRACHIASMATIC CIRCADIAN PACEMAKER INVITRO ONLY DURING THE SUBJECTIVE DAY [J].
MEDANIC, M ;
GILLETTE, MU .
JOURNAL OF PHYSIOLOGY-LONDON, 1992, 450 :629-642
[33]   Microinjection of NMDA into the SCN region mimics the phase shifting effect of light in hamsters [J].
Mintz, EM ;
Albers, HE .
BRAIN RESEARCH, 1997, 758 (1-2) :245-249
[34]   Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei [J].
Obrietan, K ;
Impey, S ;
Storm, DR .
NATURE NEUROSCIENCE, 1998, 1 (08) :693-700
[35]   Circadian regulation of cAMP response element-mediated gene expression in the Suprachiasmatic nuclei [J].
Obrietan, K ;
Impey, S ;
Smith, D ;
Athos, J ;
Storm, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :17748-17756
[36]   Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro [J].
Prosser, RA .
BRAIN RESEARCH, 1998, 808 (01) :31-41
[37]   Melatonin inhibits in vitro serotonergic phase shifts of the suprachiasmatic circadian clock [J].
Prosser, RA .
BRAIN RESEARCH, 1999, 818 (02) :408-413
[38]   Glutamate blocks serotonergic phase advances of the mammalian circadian pacemaker through AMPA and NMDA receptors [J].
Prosser, RA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (19) :7815-7822
[39]   CGMP INDUCES PHASE-SHIFTS OF A MAMMALIAN CIRCADIAN PACEMAKER AT NIGHT, IN ANTIPHASE TO CAMP EFFECTS [J].
PROSSER, RA ;
MCARTHUR, AJ ;
GILLETTE, MU .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6812-6815
[40]  
PROSSER RA, 1989, J NEUROSCI, V9, P1073